Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a multicenter, randomized, open‐Label Phase II study to evaluate the efficacy andsafety of multiple doses of SGB‐9768 in adult patients with paroxysmal nocturnalhemoglobinuria (PNH).
Epistemonikos ID: e5dff4e98e6e7d07acc61b0806a81dc910410fad
First added on: Sep 01, 2026